OPTUS Pharmaceutical Co., Ltd. (KOSDAQ: 131030)

OPTUS Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	42,152	17,811	10,409	32,555	42,423	35,157
Short-Term Investments	25,000	40,000	40,000	42,000	39,973	34,000
Trading Asset Securities	503.87	10,711	11,146	-	-	-
Cash & Short-Term Investments	67,656	68,522	61,555	74,555	82,395	69,157
Cash Growth	27.54%	11.32%	-17.44%	-9.52%	19.14%	16.88%
Accounts Receivable	9,981	9,321	7,472	6,313	3,875	7,308
Other Receivables	921.28	632.99	418.49	223.12	208.61	317.95
Receivables	10,946	9,995	7,908	6,564	4,108	13,656
Inventory	13,637	13,071	11,622	9,791	6,748	5,820
Prepaid Expenses	274.73	137.33	83.78	105.4	65.87	17.64
Other Current Assets	67	46.08	217.78	1	113.44	8.83
Total Current Assets	92,581	91,772	81,386	91,017	93,431	88,659
Property, Plant & Equipment	39,669	42,501	43,735	38,717	28,267	24,138
Long-Term Investments	12,330	13,497	10,121	9,636	8,127	5,709
Other Intangible Assets	7,102	-	-	-	-	-
Long-Term Accounts Receivable	-	-	-	-0	-0	-0
Long-Term Deferred Tax Assets	-	-	-	614.46	-	370.42
Other Long-Term Assets	611.61	1,647	963.78	53.31	71.77	91.77
Total Assets	152,316	149,460	136,240	140,038	129,897	118,969
Accounts Payable	2,552	1,889	1,536	1,519	1,213	1,118
Accrued Expenses	6,933	7,976	5,804	4,885	3,908	5,935
Current Portion of Leases	711.6	713.48	680.29	73.11	108.03	102.08
Current Income Taxes Payable	876.35	1,147	289.1	1,197	1,283	1,148
Other Current Liabilities	1,673	1,347	1,450	3,701	2,070	1,413
Total Current Liabilities	12,746	13,072	9,760	11,375	8,582	9,715
Long-Term Leases	1,098	1,359	1,918	167.1	352.32	72.91
Long-Term Deferred Tax Liabilities	435.47	494.15	14.92	-	828.05	-
Other Long-Term Liabilities	149.9	83.75	79.51	0	-	-
Total Liabilities	14,587	15,009	11,773	13,018	11,014	11,222
Common Stock	8,282	8,282	8,282	8,282	8,282	8,282
Additional Paid-In Capital	36,555	36,553	36,663	36,663	36,663	36,663
Retained Earnings	98,509	95,689	86,636	85,281	77,034	63,887
Treasury Stock	-5,655	-5,751	-6,352	-3,068	-3,068	-1,048
Comprensive Income & Other	36.91	-322.28	-762.48	-137.35	-28.86	-37.65
Shareholders' Equity	137,729	134,451	124,467	127,021	118,883	107,747
Total Liabilities & Equity	152,316	149,460	136,240	140,038	129,897	118,969
Total Debt	1,809	2,073	2,598	240.2	460.35	175
Net Cash (Debt)	65,847	66,450	58,956	74,315	81,935	68,982
Net Cash Growth	29.94%	12.71%	-20.67%	-9.30%	18.78%	16.59%
Net Cash Per Share	4319.44	4374.13	3717.13	4635.53	5079.34	4225.17
Filing Date Shares Outstanding	15.24	15.26	15.17	16.04	16.04	16.32
Total Common Shares Outstanding	15.24	15.26	15.17	16.04	16.04	16.32
Working Capital	79,834	78,700	71,626	79,642	84,849	78,945
Book Value Per Share	9035.58	8811.11	8207.04	7918.38	7411.07	6600.21
Tangible Book Value	130,627	134,451	124,467	127,021	118,883	107,747
Tangible Book Value Per Share	8569.69	8811.11	8207.04	7918.38	7411.07	6600.21
Land	5,271	5,271	5,478	5,584	5,584	1,994
Buildings	18,876	19,188	19,938	16,130	13,534	13,972
Machinery	12,346	13,387	14,420	4,577	5,406	6,017
Construction In Progress	944.97	1,999	506.56	12,183	3,291	1,981

Source: S&P Capital IQ. Standard template. Financial Sources.